Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
about
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus.Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus.Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association.Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
P2860
Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@ast
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@en
type
label
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@ast
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@en
prefLabel
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@ast
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@en
P2093
P2860
P921
P1476
Addition of Ipragliflozin to M ...... up Analysis of a Phase 3 Trial
@en
P2093
Bon Jeong Ku
Hyun Ji Cho
Ji Hyun Lee
Kyu Jeung Ahn
Kyung Wan Min
Min Seon Kim
Moon Kyu Lee
Satoshi Kokubo
Satoshi Yoshida
P2860
P304
P356
10.4093/DMJ.2017.41.2.135
P50
P577
2017-04-01T00:00:00Z